
Keywords: Drug development; Translational research; Inflammatory bowel disease; Colitis; Biomarkers; Endpoints; AA; alternative approaches; CD; Crohn's disease; 3Rs; Replacement, Reduction, Refinement; DHODH; dihydroorotate dehydrogenase; DNBS; dinitrobenzene sulph